Overview
The 40-session course at 2.0 ATA is the most common framework in the Efrati-lab neurological HBOT literature. Sessions are 90 minutes long, delivered five days a week with weekends off, completing in approximately eight weeks. Outcome assessments (cognitive testing, SPECT imaging, functional measures) are typically performed at baseline and 1–3 months after course completion to allow for post-treatment neuroplasticity.
The 40-session, 2.0 ATA protocol is the research-standard course for most neurological HBOT applications. It emerged from the Efrati Lab trials across TBI, stroke, long COVID, fibromyalgia, and age-related cognitive decline, where consistent clinical gains were observed with this specific framework. The protocol represents a practical balance between treatment intensity (daily sessions produce cumulative benefit) and feasibility (eight weeks of commitment is tolerable for most participants).
Daily attendance for eight weeks is a substantial commitment. Patients typically attend sessions at approximately the same time each day, allowing a routine to develop. Weekend breaks are intentional — they allow physiological recovery and have not been shown to reduce the benefit of the overall course. Response typically develops progressively, with many patients reporting the clearest improvements in the final weeks of the course and continuing to improve for 1–3 months after completion.
Full-course cash-pay cost in US private clinics typically ranges $6,000–$18,000. The commitment combined with the cost is a significant barrier for many patients considering off-label HBOT. For UHMS-approved indications, insurance coverage typically eliminates the direct cost, though session attendance is still a meaningful logistical commitment.
Protocol Parameters
| Pressure | 2.0 ATA |
|---|---|
| Session length | 90 minutes (60 on O₂, 2 × 5-min air breaks) |
| Frequency | 5 days/week |
| Typical course | 40 sessions over 8 weeks |
Indications
- TBI
- Stroke
- Long COVID
- Fibromyalgia
- Post-concussion syndrome
- Age-related cognitive decline (research)
The 40-session 2.0 ATA framework is the research standard for most neurological HBOT applications. Some protocols extend to 60 sessions (Hadanny TBI, Hachmo longevity); some wound-care protocols run shorter (20–30 sessions).
Evidence Base
Hadanny & Efrati reviews; Boussi-Gross 2013 (stroke); Zilberman-Itskovich 2022 (long COVID); Efrati 2015 (fibromyalgia); Hachmo 2020 (longevity biomarkers).
Cautions & Notes
- Commitment-heavy — 8-week daily attendance
- Out-of-pocket cost in most jurisdictions as neurological HBOT is not FDA-approved
- Response variability — not all patients benefit
- Interim assessment at session 20 is advisable
Practical Considerations
Patients should plan for 90-minute sessions five days a week over eight weeks. Many patients continue work, school, or other activities during an HBOT course — sessions can often be scheduled to minimise disruption. Cognitive and functional improvement often develops progressively; final assessment should be at 1–3 months post-course to capture delayed neuroplastic effects.
Frequently Asked Questions
Why 40 sessions specifically?
The 40-session framework emerged from early Efrati Lab trials showing cumulative clinical benefit. It represents a practical balance between therapeutic intensity and feasibility. Some longer courses (60 sessions) are used for specific indications with incremental additional benefit.
Can I skip weekends?
The standard protocol has weekends off. Weekend breaks are intentional and have not reduced the clinical benefit observed in trials. Daily seven-days-a-week courses are not supported by the evidence base.
What if I need to miss a session?
Occasional missed sessions are not catastrophic. The protocol tolerates some missed days, which are typically added at the end of the course. Multiple consecutive missed sessions should be discussed with the hyperbaric team.
When will I notice improvement?
Response is highly variable. Some patients notice gains in the first 2–3 weeks; others see the clearest improvement in the final weeks or in the 1–3 months after course completion.
Research disclaimer: This protocol summary is for educational purposes only. HBOT is a regulated medical treatment that must be administered under appropriate professional supervision. Always consult a qualified physician before initiating hyperbaric therapy.